News Article

Agilent Technologies to Acquire Advanced Analytical Technologies, Inc
Date: Mar 07, 2018
Source: Company Data ( click here to go to the source)

Featured firm in this article: Advanced Analytical Technologies Inc of Ankeny, IA

Agilent Technologies to Acquire Advanced Analytical Technologies, Inc.
SANTA CLARA, Calif., Mar. 7, 2018


Acquisition advances Agilent's growth strategy

Highly attractive business with robust growth track record and prospects

Combination strengthens customer value proposition with complementary technologies and solutions

Opportunity to accelerate expansion into adjacent businesses

Agilent Technologies Inc. (NYSE: A) today announced that it has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) solutions for fully-automated analysis of a range of molecules for $250 million in cash. This acquisition will enhance Agilent's existing expertise and technology, while giving customers a more comprehensive set of solutions.

"This acquisition is another great example of Agilent effectively deploying our capital to create value for our customers and our shareholders. AATI's complementary products strengthen our existing strong portfolio of solutions and provide further opportunities to accelerate our growth," said Patrick Kaltenbach, president of Agilent's Life Sciences and Applied Markets Group.

Automated electrophoresis is a commonly used separation technique to analyze biomolecules such as nucleic acids (RNA and DNA), proteins, carbohydrates and small molecules. It has a broad range of applications and is used across a variety of industries segments including pharma and biopharma, academia and government, clinical and diagnostics, food, environmental and forensics, and chemical and energy.

AATI has developed compelling CE technologies that provide key advances in sensitivity and resolution to address a wide range of applications. AATI solutions are comprised of instruments, software and consumables aimed at simplifying complex workflows.

"Technology advances in genomics, metabolomics, and proteomics are driving growth and demand for innovative new solutions," said Dr. Stefan Schuette, vice president and general manager of Agilent's Liquid Phase Separations Division. "The value of this acquisition is in the expanded capabilities for emerging applications that Agilent and AATI together can offer."

"Each company brings expertise and a culture of innovation," said Steven J. Lasky, Ph.D., AATI CEO. "I believe we will be able to serve customers better and provide even greater opportunities for our employees by joining Agilent."

Founded in 1998, AATI is based in Ankeny, Iowa and employs 101 employees.

The transaction is subject to customary closing conditions and regulatory approval.
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at